Evidence map›Paper›PMID 40837126›Full record

ArticleUrology case reports2025

Augmented reality assisted MRI/US fusion for non-rectal fully trans-perineal prostate biopsy.

Braden Millan, Nikhil Pramod, Jaskirat Saini, Ruben Blachman-Braun, Baris Turkbey, Sheng Xu, Ming Li, Michael Evans, Gabreille Stefy, Sandeep Gurram and 2 more

Abstract readCase Reports
In one paragraph

Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Braden MillanUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Nikhil PramodUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Jaskirat SainiUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Ruben Blachman-BraunUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Baris TurkbeyMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Sheng XuNational Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, USA.
Ming LiNational Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, USA.
Michael EvansMediView XR Inc., Cleveland, OH, USA.
Gabreille StefyMediView XR Inc., Cleveland, OH, USA.
Sandeep GurramUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Bradford WoodCenter for Interventional Oncology, National Institutes of Health, Bethesda, MD, USA.
Peter A PintoUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Augmented reality (AR) technologies enable the superimposition of imaging upon a patient in real time with three dimensional instrument tracking during procedures. We sought to demonstrate the feasibility of using an AR system (XR90, MediView XR Inc., Cleveland, OH) to fuse a pelvic multi-parametric magnetic resonance image segmentation with ultrasound to perform a non-rectal, fully trans-perineal (FTP), AR-assisted prostate biopsy. AR-assisted biopsy results were congruent with standard fusion biopsy results, showing benign prostate tissue. No adverse events occurred. Limitations include the current workflow and reliance on a non-specialized ultrasound probe.

Indexed as

Augmented realityFully transperineal prostate biopsyMRI/US fusionProstate biopsyProstate cancer

Identifiers

PMID40837126
PMCPMC12362000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.